Article Details
Retrieved on: 2024-04-17 11:47:49
Tags for this article:
Click the tags to see associated articles and topics
Summary
CureVac and MD Anderson are partnering to develop mRNA-based cancer vaccines using bioinformatics for antigen discovery and validation. The collaboration leverages their combined expertise in translational drug development and manufacturing.
Article found on: www.tipranks.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here